Tirzepatide

What Is Tirzepatide?

Tirzepatide is an injectable drug used to treat diabetes and reduce blood sugar levels. It is administered once weekly. While many similar drugs are available, this one has the added benefit of treating two problems at once. Those with type 2 diabetes are the target population, but off-label use for weight loss is possible. Tirzepatide works best when combined with other healthful lifestyle choices, such as a nutritious diet and regular physical activity 30min 3-4 times a week.

Tirzepatide RESEARCH

Tirzepatide is a medicine being researched for its potential to help persons with obesity and type 2 diabetes lose weight. It also helps to better manage their blood sugar levels.

It has shown encouraging results in preliminary investigations, which may thrill doctors who treat obese patients. Throughout a 26-week study, those who took Tirzepatide lost an average of 11% of their body weight, while those who took a placebo lost an average of 2.5%. Tirzepatide has also been proven to benefit glycaemic management, blood pressure, and cholesterol. The participants took a maximum tolerated dose of tirzepatide for 36 weeks, which yielded the expected weight reduction of 20.9 percent with improvements in blood pressure, blood sugar metrics and lipid levels.

How Does Tirzepatide Work?

Targeting and activating GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide) receptors is how Tirzepatide achieves its medicinal value. These receptors are essential for controlling hunger and blood sugar levels. In reaction to eating, the body produces the hormones GLP-1 and GIP. They signal the brain to reduce hunger and promote feelings of fullness, which together aid in lowering blood sugar levels.

It is an agonist, activating the GLP-1 and GIP receptors more than the body’s natural hormones. Tirzepatide’s ability to stimulate insulin secretion, lower blood sugar levels, and improve satiety to aid in weight loss is well established. Tirzepatide’s potential metabolic benefits extend beyond its effects on GLP-1 and GIP receptors. It may include, for example, reduced inflammation and improved lipid profiles.

What Is The Function Of Tirzepatide?

You will receive a syringe with Tirzepatide. The Tirzepatide is to be used once weekly. The medicine can be injected into the upper arm, thigh, or abdomen. It is most effective when stored at a cool (36°F to 46°F) temperature.

How Often Should Tirzepatide Be Taken?

All patients should start taking Tirzepatide at a lower dose of 2.5 mg to test how well it is tolerated. If your doctor tells you to do anything, you should do it. The recommended dosage plan for Tirzepatide is as follows:

What Are Tirzepatide Side Effects?

Tirzepatide is an investigational medication that is still undergoing clinical trials. But, early studies have shown that it may cause side effects in some patients. In clinical trials, the following are the most frequently reported adverse effects:

Hypoglycemia (low blood sugar)
Gallbladder disease or gallstones
Kidney problems, including acute kidney injury or worsening of chronic kidney disease
Pancreatitis (inflammation of the pancreas)
Thyroid cancer

It is important to note that the safety and efficacy of Tirzepatide are still being evaluated. More side effects may be identified as clinical trials continue. Patients considering Tirzepatide should discuss the potential benefits and risks with their healthcare provider.

Does The Food And Drug Administration Approve Tirzepatide For Weight Loss?

Tirzepatide, sold under the brand Mounjaro/Zepbound, has been approved by the FDA for treating type 2 diabetes and BMI>30. Adults with diabetes can use this drug to treat life-threatening hypoglycemia (low blood sugar). Tirzepatide may not be an appropriate or safe option for all patients.

Tirzepatide Or Semaglutide: Which Is More Effective?

Tirzepatide and Semaglutide are both medications being studied for their potential to promote weight loss. While both drugs work by activating GLP-1 receptors to increase insulin secretion and reduce appetite, there are differences in how they are administered and their potential side effects. Tirzepatide is a medication that is administered once weekly by subcutaneous injection. Early clinical trials have shown that it may promote weight loss of up to 15-21%.

It also causes side effects such as nausea, diarrhea, vomiting, and injection site reactions. Semaglutide is an FDA-approved medication for treating type 2 diabetes, but it is also being studied at a higher dose as a weight loss medication. It is administered once weekly by subcutaneous injection or as a daily oral tablet. Clinical trials have shown that Semaglutide can promote weight loss of up to 15%. But may also cause side effects such as nausea, diarrhea, vomiting, and constipation. It is important to note that both medications are still being studied, and their safety and efficacy for weight loss may vary depending on individual factors such as age, sex, and medical history. Ultimately, the decision to use either medication for weight loss should be made in consultation with a healthcare provider who can evaluate each patient’s potential benefits and risks.

Who Should Not Use Tirzepatide?

Both the safety and effectiveness of tirzepatide are currently being determined through ongoing clinical research. Therefore, Tirzepatide use should be approached with caution or avoided altogether in a small subset of the population. For example:

Those with a family history of medullary thyroid cancer (MTC) or MENS Type 2 (MEN 2). Those with a history of MTC or MEN 2 should avoid taking tirzepatide because of the drug’s link to an increased risk of thyroid cancers in animal studies.

Those who have previously suffered from pancreatitis. Pancreatitis is an inflammation of the pancreas that can be exacerbated by tirzepatide. Tirzepatide shouldn’t be taken by those who have had pancreatitis.

Those who suffer from severe cases of digestive difficulties or motility issues. The gastrointestinal side effects of tirzepatide include nausea, vomiting, and diarrhea. These adverse effects may more likely occur in people with a severe gastrointestinal illness or motility difficulties. Those who have serious kidney damage. Those with severe renal impairment may be at a higher risk for side effects from tirzepatide because the drug is flushed out of the body via the kidneys.

Say "Hello" to a New You

Call us today to schedule an appointment.

Tirzepatide

Say "Hello" to a New You

WHO WE ARE